FBT: Summary for 1ST TR NYSE BIO IDX - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, November 25, 2009, 2:48pm EST - Canadian Markets close in 1 hour and 12 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

First Trust AMEX Biotechnology Index (FBT)

At 14:03 EST: 27.048 USD

0.168 (0.63%)

MORE ON FBT

Quotes

Summary

Charts

News & Info

ETF

Analyst

1ST TR NYSE BIO IDX (PCX:FBT) Delayed quote data

Last Trade:	27.048
Trade Time:	2:03PM EST
Change:	0.168 (0.63%)
Prev Close:	26.88
Open:	26.87
Bid:	27.04 x 1500
Ask:	27.06 x 2000
NAV¹:	23

¹As of 30-Jan-08

Day's Range:	26.87 - 27.048
52wk Range:	16.39 - 29.52
Volume:	18,443
Avg Vol (3m):	40,089.4
YTD Return (Mkt)²:	3.53%
Net Assets²:	73.24M
P/E (ttm)²:	29.37
Yield (ttm)²:	NaN%

²As of 31-Dec-07

First Trust AMEX Biotechnology Index (FBT)

1d 5d 3m 6m 1y 2y 5y

Add FBT to Portfolio

Download Data

HEADLINES

•	[$$] What's Bad for Health Care Reform is Good for Health ETFs
	at RealMoney by TheStreet.com (Wed, Nov 4)

•	Biotech Sector Pullback: Good Time to Buy at a Discount
	at Seeking Alpha (Wed, Oct 28)

•	September ETFs: Best and Worst Industry Performers
	at Seeking Alpha (Thu, Oct 1)

•	The Cruelest Of All Months
	IndexUniverse.com (Thu, Sep 10)

•	Will Bear Market End with Disgust for Capitalism?
	at Minyanville.com (Mon, Aug 31)

•	5-Star Stocks on the Upswing
	at Motley Fool (Tue, Aug 18)

•	Don Dion's Weekly ETF Blog Wrap
	at TheStreet.com (Sun, Jul 26)

•	Don Dion's Weekly ETF Winners and Losers
	at TheStreet.com (Sat, Jul 25)

•	[video] Stock Wrap: The Real Story, July 23
	at TheStreet.com (Thu, Jul 23)

•	[$$] How Human Genome Moved the ETFs
	at RealMoney by TheStreet.com (Mon, Jul 20)

•	Human Genome rally powers biotech ETFs
	at MarketWatch (Mon, Jul 20)

•	Today's 5-Star Movers
	at Motley Fool (Wed, Jun 3)

More Headlines for FBT...

FUND BASICS

Category:	Specialty-Health
Fund Family:	First Trust Portfolios
Index Tracked:	S&P 500 TR
Total Assets:	73.24M
Legal Type:	Exchange Traded Fund

Fund Profile - Holdings

PERFORMANCE & RISK

YTD Return:	3.65%
3y Avg Return:	N/A
5y Avg Return:	N/A
Beta (3y):

Performance Details - Risk Details

FUND SUMMARY

The investment seeks to track the price and yield performance, before fees and expenses, of the Amex Biotechnology index. The fund will normally invest at least 90% of assets in stocks that comprise the index. The index measures the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. The fund is nondiversified.

Fund Profile

Add to Portfolio

Email to a Friend

•